Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study page now states that recruitment has ended and includes new sections to help readers understand and join the study. The Intervention/Treatment heading has been standardized.
    Difference
    0.3%
    Check dated 2026-06-13T05:20:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a newer build of the page content.
    Difference
    0.0%
    Check dated 2026-06-05T22:15:28.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4, replacing the previous v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-15T14:50:54.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page’s software/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**. This reflects a site revision marker rather than a change to the clinical trial’s study information.
    Difference
    0.0%
    Check dated 2026-04-24T05:44:09.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:29:36.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added the term 'Small cell lung carcinoma' to the page content and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:24:05.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.